BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8128447)

  • 21. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.
    Sun Z; Chen YH; Wang P; Zhang J; Gurewich V; Zhang P; Liu JN
    Biochim Biophys Acta; 2002 Apr; 1596(2):182-92. PubMed ID: 12007600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate.
    Castro MJ; Kingston IB; Anderson S
    Anal Biochem; 1995 Apr; 226(2):225-31. PubMed ID: 7793622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New fluorogenic peptide substrates for plasmin.
    Kato H; Adachi N; Ohno Y; Iwanaga S; Takada K; Sakakibara S
    J Biochem; 1980 Jul; 88(1):183-90. PubMed ID: 6447693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding and activation of plasminogen at the surface of human keratinocytes.
    Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
    Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro.
    Taitzoglou IA; Tsantarliotou M; Zervos I; Kouretas D; Kokolis NA
    Reproduction; 2001 Jan; 121(1):131-7. PubMed ID: 11226036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine and its thiolactone impair plasmin activity induced by urokinase or streptokinase in vitro.
    Kolodziejczyk-Czepas J; Talar B; Nowak P; Olas B; Wachowicz B
    Int J Biol Macromol; 2012 Apr; 50(3):754-8. PubMed ID: 22197896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The roles of native milk proteinase and its zymogen during proteolysis in normal bovine milk.
    de Rham O; Andrews AT
    J Dairy Res; 1982 Nov; 49(4):577-85. PubMed ID: 6217233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action and some properties of a tissue activator of plasminogen.
    McCall DC; Kline DL
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):116-26. PubMed ID: 16955970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activation mechanism of human plasminogen.
    Rickli EE
    Thromb Diath Haemorrh; 1975 Nov; 34(2):386-95. PubMed ID: 128150
    [No Abstract]   [Full Text] [Related]  

  • 31. Binding of anisoylated Lys-plasminogen streptokinase activator complex to cells in culture.
    Vasudevan J; Humphries JE; Gonias SL
    Thromb Haemost; 1993 Apr; 69(4):370-4. PubMed ID: 8388580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
    Ryan TJ; Keegan MC
    Biochim Biophys Acta; 1985 Aug; 830(2):187-94. PubMed ID: 3160389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of plasminogen by Streptococcus mutans.
    Jones MN; Holt RG
    Biochem Biophys Res Commun; 2004 Sep; 322(1):37-41. PubMed ID: 15313170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of plasmin activity by oleic acid.
    Higazi AA; Finci-Yeheskel Z; Samara AA; Aziza R; Mayer M
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):863-6. PubMed ID: 1532491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of plasmin activity by aspirin.
    Milwidsky A; Finci-Yeheskel Z; Mayer M
    Thromb Haemost; 1991 Apr; 65(4):389-93. PubMed ID: 1829277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesis.
    Wang H; Doll JA; Jiang K; Cundiff DL; Czarnecki JS; Wilson M; Ridge KM; Soff GA
    Cancer Res; 2006 Jul; 66(14):7211-5. PubMed ID: 16849568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmin potency estimates: influence of the substrate used in assay.
    Philo RD; Gaffney PJ
    Thromb Haemost; 1981 Apr; 45(2):107-9. PubMed ID: 6454987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elimination of the Cys558-Cys566 bond in Lys78-plasminogen--effect on activation and fibrin interaction.
    Linde V; Nielsen LS; Foster DC; Petersen LC
    Eur J Biochem; 1998 Jan; 251(1-2):472-9. PubMed ID: 9492320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion of proteolytically modified form (Lys-form) of human plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):411-9. PubMed ID: 6459659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.